Azka Ali, MD, is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute with a clinical focus on breast medical oncology. She is board certified in Internal Medicine, Medical Oncology, and Hematology. Dr. Ali graduated from the Medical University of South Carolina (MD, 2015), completed Internal Medicine residency at the University of Florida (Chief Resident, 2018–2019), and finished Hematology/Medical Oncology fellowship at the University of Florida (2022). Her treatment philosophy emphasizes patient-centered, shared decision-making while incorporating the most recent FDA-approved therapies. Her research interests include developmental therapeutics, improving outcomes for patients with recurrent and metastatic disease, and designing oncology clinical trials, with work spanning topics such as endocrine therapy adherence, targeted therapies, and real-world outcomes in breast cancer.
Assistant Professor
Medical School
Residency
Fellowship